Stock Events

Stock Events

Abeona Therapeutics 

$5.67
99
+$0.14+2.53% Today

Statistics

Day High
5.74
Day Low
5.52
52W High
7.54
52W Low
4
Volume
604,970
Avg. Volume
1,163,188
Mkt Cap
307.26M
P/E Ratio
5.82
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.63
0.15
0.93
1.71
Expected EPS
-0.223333
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-127.47MNet Income

Analyst Ratings

20.00Average Price Target
The highest estimate is 20.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABEO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap29.53B
Biogen focuses on developing therapies for neurological and neurodegenerative diseases, directly competing with Abeona's gene therapy approach for similar disorders.
Pfizer
PFE
Mkt Cap149.38B
Pfizer has a broad portfolio including gene therapies targeting rare diseases, overlapping with Abeona's focus areas.
Sangamo Therapeutics
SGMO
Mkt Cap62.14M
Sangamo Therapeutics specializes in genomic medicine, including gene therapy, competing in the same space as Abeona for genetic disorders.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.81B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals for rare diseases, directly competing with Abeona's rare disease focus.
Ultragenyx Pharmaceutical
RARE
Mkt Cap2.16B
Ultragenyx Pharmaceutical targets rare and ultra-rare diseases with its drug development, similar to Abeona's focus.
Sarepta Therapeutics
SRPT
Mkt Cap1.62B
Sarepta Therapeutics focuses on the discovery and development of RNA-based therapeutics and gene therapy for rare diseases, competing with Abeona's gene therapy approach.
Vertex Pharmaceuticals
VRTX
Mkt Cap112.92B
Vertex Pharmaceuticals engages in developing therapies for treating cystic fibrosis and other serious diseases, competing in the rare disease market with Abeona.
Novo Nordisk
NVO
Mkt Cap194.35B
Novo Nordisk focuses on a broad range of treatments including for rare diseases, potentially competing with Abeona in the gene therapy and rare disease market.

About

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-based gene therapy solutions through its proprietary AIM vector platform. The company, which was founded in 1974 and is headquartered in New York, New York, changed its name to Abeona Therapeutics Inc. in June 2015, having previously been known as PlasmaTech Biopharmaceuticals, Inc.
Show more...
CEO
Mr. Joseph Walter Vazzano CPA
Employees
136
Country
United States
ISIN
US00289Y2063

Listings

STU
DE
PCJ.STU
F
DE
PCJ.F
XNAS
US
ABEO
LSE
GB
0H7R.LSE

0 Comments

Share your thoughts

FAQ

What is Abeona Therapeutics stock price today?▼
The current price of ABEO is $5.67 USD — it has increased by +2.53% in the past 24 hours. Watch Abeona Therapeutics stock price performance more closely on the chart.
What is Abeona Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abeona Therapeutics stocks are traded under the ticker ABEO.
Is Abeona Therapeutics stock price growing?▼
ABEO stock has risen by +5.39% compared to the previous week, the month change is a +3.28% rise, over the last year Abeona Therapeutics has showed a -7.95% decrease.
What is Abeona Therapeutics market cap?▼
Today Abeona Therapeutics has the market capitalization of 307.26M
When is the next Abeona Therapeutics earnings date?▼
Abeona Therapeutics is going to release the next earnings report on August 12, 2026.
What were Abeona Therapeutics earnings last quarter?▼
ABEO earnings for the last quarter are -0.3 USD per share, whereas the estimation was -0.34 USD resulting in a +10.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abeona Therapeutics revenue for the last year?▼
Abeona Therapeutics revenue for the last year amounts to 0 USD.
What is Abeona Therapeutics net income for the last year?▼
ABEO net income for the last year is -127.47M USD.
How many employees does Abeona Therapeutics have?▼
As of June 15, 2026, the company has 136 employees.
In which sector is Abeona Therapeutics located?▼
Abeona Therapeutics operates in the Health & Wellness sector.
When did Abeona Therapeutics complete a stock split?▼
The last stock split for Abeona Therapeutics was on July 05, 2022 with a ratio of 1:25.
Where is Abeona Therapeutics headquartered?▼
Abeona Therapeutics is headquartered in Cleveland, United States.